Evaluation and identification of hepatitis B virus entry inhibitors using HepG2 cells overexpressing a membrane transporter NTCP

Masashi Iwamoto(Rockefeller University), Takaji Wakita(National Institute of Infectious Diseases), Masayoshi Fukasawa(National Institute of Infectious Diseases), Senko Tsukuda(National Institute of Infectious Diseases), Hussein Hassan Aly(National Institute of Infectious Diseases), Osamu Koiwai(Tokyo University of Science), Akira Fujimoto(National Institute of Infectious Diseases), Hiroyuki Kusuhara(The University of Tokyo), Koichi Watashi(Tokyo University of Science), Hideki Aizaki(National Institute of Infectious Diseases), Ryosuke Suzuki(National Institute of Infectious Diseases), Takayoshi Ito(SHOWA Medical University)
Biochemical and Biophysical Research Communications
December 14, 2013
10.1016/j.bbrc.2013.12.052
Cited by 330

Related Papers

Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells
|Proceedings of the National Academy of Sciences|2006|350
Cyclosporin A and Its Analogs Inhibit Hepatitis B Virus Entry Into Cultured Hepatocytes Through Targeting a Membrane Transporter, Sodium Taurocholate Cotransporting Polypeptide (NTCP)
|Hepatology|2013|259
Epidermal growth factor receptor is a host-entry cofactor triggering hepatitis B virus internalization
|Proceedings of the National Academy of Sciences|2019|241
Critical challenges and emerging opportunities in hepatitis C virus research in an era of potent antiviral therapy: Considerations for scientists and funding agencies
|Virus Research|2018|169
Interleukin-1 and Tumor Necrosis Factor-α Trigger Restriction of Hepatitis B Virus Infection via a Cytidine Deaminase Activation-induced Cytidine Deaminase (AID)
|Journal of Biological Chemistry|2013|166